Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Impact, Reach, and Community Involvement of #ContinuumCase
Education, Research, and Methodology
S39 - Broadening the Scope of Medical Education in Neurology (4:30 PM-4:42 PM)
006

As the leading narrative review and CME journal, Continuum articles feature cases that demonstrate practical application of the latest research and optimal clinical care. These cases can be used on social media platforms like X, which offer a powerful way to reach a global audience.

To demonstrate the global reach of a case-based teaching initiative that feature cases from Continuum articles posted on the social media platform X (Twitter). 

Continuum cases (#ContinuumCase) were posted on X starting September 8, 2022. Polls surveyed community knowledge and engagement. X analytics were collected from each post; the artificial intelligence analytic program Fedica was used to visualize the global reach of the two posting accounts.

Between September 8, 2022, and October 4, 2023, two accounts posted 72 unique Continuum cases (@LyellJ, 42 cases; @caseyalbin, 30 cases) from 56 articles in 11 issues. Most (91.6%, 66/72) are searchable using the hashtag #ContinuumCase. The median length is 7.5 posts (interquartile range [IQR] 6-11). The mean number of “likes” per case is 174 (IQR 93-198) and the mean number of “reposts” per case is 47 (IQR 26-52). On average, cases have been viewed by 60,920 X users (IQR 27,850-72,200). Cumulatively, the cases have garnered 4.2 million views. Most (91.6%, 66/72) of the cases feature a poll and an average of 596 people voted on case management in the polls (IQR for poll participation 252-656). @LyellJ and @caseyalbin have followers from more than 130 countries. The USA, India, the United Kingdom, and Canada account for 59% of followers of both accounts.

Continuum cases have engaged clinical learners through case-based teaching on social media, reached a global audience, and generated high engagement. Given the low barrier to access, social media may be a preferred teaching platform for some educators and learners.

Authors/Disclosures
Casey S. Albin, MD (Emory Healthcare)
PRESENTER
Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from American Academy of Neurology. Dr. Albin has received publishing royalties from a publication relating to health care. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving as a Instructor with Resuscitation Leadership Academy.
Amanda Doering (American Academy of Neurology) Ms. Doering has nothing to disclose.
Thomas Pacific Thomas Pacific has received personal compensation in the range of $100,000-$499,999 for serving as a Publisher with Wolters Kluwer .
James E. Siegler III, MD (University of Chicago) Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various medicolegal cases. The institution of Dr. Siegler has received research support from Viz.ai.
Lyell K. Jones, MD, FAAN (Mayo Clinic) Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a member of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.